Inhibition of SOAT1 Suppresses Glioblastoma Growth via Blocking SREBP-1–Mediated Lipogenesis
Feng Geng(The Ohio State University), Deliang Guo(Wuhan University), Craig Horbinski(Northwestern University), Ji Young Yoo(The University of Texas MD Anderson Cancer Center), Xiaokui Mo(The Ohio State University), Jianjie Ma(National Yang Ming Chiao Tung University), Arnab Chakravarti(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), José Javier Otero(Florida International University), Ichiro Nakano(University of Alabama at Birmingham), Vinay K. Puduvalli(The University of Texas MD Anderson Cancer Center), Balveen Kaur(Augusta University), Chunming Cheng(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Sunghak Kim(University of Alabama at Birmingham), Étienne Lefai(Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement), Xiaoning Wu(The Ohio State University), Jeffrey Yunhua Guo(The Ohio State University), Xiang Cheng(Union Hospital), Peng Ru(The Ohio State University), Brian Hurwitz(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute)
Cited by 332
Related Papers
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
|Neuro-Oncology|2020|1.1k
Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3
|Proceedings of the National Academy of Sciences|2013|644
Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles
|Science Advances|2018|614
Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses
|Proceedings of the National Academy of Sciences|2006|360